• Guidance on operational microplanning for COVID-19 vaccination is a companion document to the Guidance on developing a national deployment and vaccination plan. It provides a  framework for countries to develop their national strategies.

English | French  |  Spanish  |  Portuguese

Country experiences with COVID-19 vaccination: Mainstreaming & integration with immunization programme services and PHC highlights country examples of good practices and innovation to mainstream/integrate COVID-19 vaccination in the main critical areas of vaccination

• Information on COVID-19 vaccines, targeted at Regulatory Agencies: vaccines eligible for WHO prequalification, vaccines under assessment, Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process, WHO List of Prequalified Vaccines, procedures and fees, post-prequalification procedures, prequalification reports, guidance documents, alternative evaluation pathways, and complaints handling.

• The Global Compendium of Country Knowledge on COVID-19 Vaccination aims at offering an organized information space that: Facilitates countries, development partners, NGOs and entities supporting vaccine rollout, access to other country’s documented successes and challenges of their COVID-19 vaccination programmes; this would potentially inform about emerging issues in real-time and thus open a pathway for immediate solutions.
• Country experiences with COVID-19 vaccination: Mainstreaming & integration with immunization programme services and PHC highlights country examples of good practices and innovation to mainstream/integrate COVID-19 vaccination in the main critical areas of vaccination.
• The Learning Collective Initiative in Covid-19 Vaccine Delivery Partnership is a series that aims to collect and share key learnings, best practices and challenges in planning and implementing COVID-19 vaccination uptake.Slides and recordings from past sessions as well as registration links for future sessions are available here .
• Slide set summarizing the WHO latest recommendations on COVID-19 vaccines and considerations for current and future COVID-19 vaccination. The objective is to help orient the Ministry of Health (MoH) and National Immunization Advisory Committee Group (NITAG) in their COVID-19 vaccine strategic decisions The information contained in this version 3 of the slide set is current as of 31 October 2022

English | French | Spanish

• The Infection prevention and control aide memoire is for policy makers, immunization programme managers, infection prevention and control (IPC) focal points at national, sub-national, and facility level, as well as for health workers involved in COVID-19 vaccination delivery. This document summarizes the key IPC principles to consider and the precautions to take for safely delivering COVID-19 vaccines. 
• Training on infection prevention and control 

• The COVAX No-Fault Compensation Program webpage brings more information on NFC for Advance Market Commitment (AMC) Eligible Economies . The Program provides fair, no-fault, lump sum compensation to eligible individuals who suffer certain serious adverse events after receiving vaccines distributed through the COVAX Facility until 30 June 2022. 

• The COVID-19 Vaccine Introduction and deployment Costing tool (CVIC tool) supports credible COVID-19 vaccination costing to facilitate a dialogue with stakeholders while maintaining sensitivity to protecting essential health services.
• What is the CVIC tool? This video, available in English, French and Spanish, shows the importance of COVID-19 vaccine costing and the role of the COVID-19 Vaccine Introduction and deployment Costing tool (CVIC tool). 
• Training on how to use the CVIC tool is available in English and French.
• The OpenWHO course CVIC tool: using the COVID-19 Vaccine Introduction and deployment Costing Tool targets national programme managers and personnel who have been involved in the costing, budgeting or financing processes of COVID-19 vaccine delivery in a country.
• COVID-19 vaccination costing Q&A provides a basic introduction on the importance of a good costing exercise for COVID-19 vaccine roll-out, how it can be done, and how to seek technical assistance. 
• WHO Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines webinar series align with countries’ immediate and medium-term needs. Session materials are also available online.
• The costs of delivering COVID-19 vaccine in 92 AMC countries report presents broad estimates of the costs of delivering COVID-19 vaccines to approximately 20% of the population in the 92 Advance Market Commitment (AMC) countries.
• COVID-19 vaccination financing and budgeting Q&A provides a basic introduction to the possible financing and budgeting arrangements around the COVID-19 vaccination roll-out. 

• COVID-19 vaccination: Supply and logistics guidance helps national and subnational supply and logistics focal points to prepare and strengthen their supply chain strategies to receive, store, distribute and manage the COVID-19 vaccines and their ancillary products, in line with their national deployment and vaccination plan (NDVP).
• WHO Expanded Programme on Immunization Logistics Forecasting Tool   explains how to forecast the needs for vaccines, equipment for safe vaccination, as well as cold chain and ambient storage capacities for national immunization programmes.
• Ultra-low temperature (ULT) storage and transport for vaccines  Some of the COVID-19 vaccines may need to be kept at ultra-low temperatures (ULTs) to maintain their potency. This resource provides immunization programme managers and cold chain managers with an overview of the options to overcome the challenges of maintaining the vaccine in ultra-low temperatures during storage and transport.
• Operational guidance on establishing an ultra-cold chain system in support of the Pfizer-BioNTech COVID-19 vaccine rollout is focused on establishing and managing an ultracold chain (UCC) system. It provides practical guidance to support countries in planning and selecting the appropriate UCC system design and equipment based on their local context. It outlines the considerations to ensure the UCC equipment will remain functional and utilized even after the Pfizer-BioNTech COVID-19 Vaccine supply has been fully utilized.
• Acceptance of available traditional vaccine supply with reduced shelf-life advocates for countries to consider acceptance of traditional vaccines with reduced shelf life and guide decision-making tailored to the specific situation at hand, referencing already existing WHO publications.
• Guidance on utilization of COVID-19 vaccines before the date of expiry help countries ensure that all COVID-19 vaccine doses are optimally utilized, and wastage is minimized. 
• Injection safety in the context of coronavirus disease (COVID-19) vaccination policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and broad short-term and long-term solutions to address and alleviate supply shortages related to vaccine products with non-standard dose volumes.  
• Guidance on safe and effective management and disposal of wastes  generated by COVID-19 vaccination activities at the facility level.
• Guidance on how to manage and safely dispose of vaccination waste at health facility level (applicable for non-live vaccines, including COVID-19 vaccines): Poster format
• How to verify the expiration date for Pfizer-BioNTech COVID-19 Vaccine paediatric formulation using the QR code? Job aid on how to verify the expiration date for Pfizer-BioNTech COVID-19 Vaccine paediatric formulation using the QR code found on the secondary packaging label.
• Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran). Training modules on the handling, storing and managing the supply of Pfizer BioNtech COVID-19 vaccine. It is recommended to select the appropriate slides/training modules relevant to the profile of your participants.

• The COVID-19 vaccination training for health workers provides key information and job aides for vaccinators on how to safely and efficiently administer vaccines.
• COVID-19 vaccine simulation exercises help countries to prepare for strategies, communications, supply and logistics, vaccine safety and regulatory aspects of COVID-19 vaccination.
• Training on how to use COVID-19 vaccine simulation exercises 
• Global Capacity Webinars provide helpful information on key aspects of COVID-19 vaccination for national/subnational focal points and health workers.
• The COVID-19 vaccine checklist is for frontline health workers planning a COVID-19 vaccination session. This checklist can help them to prepare and complete a COVID-19 vaccination session at a fixed post or outreach session.
• The Health Worker Communication for COVID-19 Vaccination Flow Diagram supports health workers by outlining key steps and messages, including for pregnant and lactating women, to communicate during a COVID-19 vaccination session.
• Why are there extra doses of vaccine in the vaccine vial?   This job aid explains extra doses of vaccine in multi-dose vials and provides guidance for their use.
• Supportive supervision for COVID-19 vaccination is intended for supervisors who are supporting staff conducting COVID-19 vaccination. Use this checklist to prepare for and conduct supervisory visits, either on-site or remotely.
• How to manage COVID-19 vaccines without VVM at vaccination service points?   explains how WHO EUL COVID-19 vaccines without a vaccine vial monitor (VVM) should be handled at the vaccination site, to ensure that safe and potent vaccines are administered.

What you need to know:

• The Pfizer BioNTech (BNT162b2) COVID-19 vaccine
• The Oxford/AstraZeneca (ChAdOx1-S [recombinant] vaccine) COVID-19 vaccine
• The Janssen Ad26.COV2.S COVID-19 vaccine
• The Moderna COVID-19 (mRNA-1273) vaccine
• The Sinovac-CoronaVac COVID-19 vaccine
• The Sinopharm COVID-19 vaccine
• The CanSino Biologics Ad5-nCoV-S [recombinant] COVID-19 vaccine
• The Novavax COVID-19 vaccine

• These tools were designed to respond to these challenges and support planning and implementation for COVID-19 vaccination. They offer practical guidance on a range of areas – from planning to data gathering and evaluation, to specific strategies for community engagement and managing rumours and misinformation.

• COVID-19 vaccines: safety surveillance manual highlights the importance for countries to include preparedness plans for COVID-19 vaccine safety and helps them to develop this plan in the NDVP, building on WHO guidance.
• The recognizing anaphylaxis training video  provides a brief (4 minute) overview on how to recognize anaphylaxis vs. an immunization stress-related response.
• The identifying and managing anaphylaxis training video provides a brief overview on how to manage anaphylaxis.
• Vaccine safety poster for health workers on how to monitor and report COVID-19 vaccine, side effects
• The Adverse Events Following Immunization (AEFI) page comprises all AEFI resources including aide-mémoires, worksheet, updated AEFI manual as well as the pre-published document on anaphylaxis.
• Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19) aims to increase awareness about TTS in the context of COVID-19 vaccination and help healthcare providers in the assessment and management of potential TTS case.

• The Monitoring COVID-19 Vaccination guidance provides considerations for: minimum and optional data to collect as vaccines are being rolled out and delivered; key performance indicators and the anticipated use of these – to measure the performance of key components of the immunization system and to take corrective action when needed; and the use of information systems to collect, store, analyze and disseminate any relevant information.
• COVID-19 vaccination data is available on the WHO Coronavirus (COVID-19) Dashboard. These data are viewed by selecting “Vaccination” from the dropdown panel on the left-hand side of the map. Currently, the dashboard incorporates information useful to track global vaccine rollout, including total vaccination doses administered, persons vaccinated with at least one dose, and start date of vaccinations, by country, territory and area.

Post introduction evaluation

Following new vaccine introduction into a routine immunization programme, the purpose of a post-introduction vaccine evaluation (PIE) is to evaluate the impact of the vaccine introduction on the country’s immunization programme and to rapidly identify problems needing correction as vaccination expands in country.

After COVID-19 vaccine introduction, in the mid- to long-term phase (between 6–18 months after introduction), a classic or full COVID-19 vaccine PIE (cPIE) is recommended. For countries interested in implementing the classic cPIE, please refer to the COVID-19 vaccine post-introduction evaluation (‎cPIE)‎ guide: interim guidance, 25 August 2021.

• PAHO has also developed resources for the Americas region to help governments to prepare the introduction and successful roll-out of COVID-19 vaccines, as well as resources for the general public to answer questions related to COVID-19 candidate vaccines. 
• COVID-19 immunization in refugees and migrants: principles and key considerations: interim guidance
• Frequently asked questions - COVID-19 vaccines and breastfeeding based on WHO SAGE interim recommendations provides answers to frequently asked questions (FAQs) about COVID-19 vaccination and breastfeeding. It is intended to assist health workers and the public, including mothers who are breastfeeding or expressing milk.
• Updated WHO Guidance on COVID-19 vaccination for pregnant and lactating women: This document provides background on evidence, WHO interim recommendations, tools and resources about COVID-19 vaccination during pregnancy and lactation.
• Safe Ramadan practices in the context of COVID-19 - This guidance focuses on SARS-CoV-2 transmission, public health and social measures, vaccination, and the use of masks in the context of Ramadan.
• Disability considerations for COVID-19 vaccination presents considerations and actions for the following stakeholders to ensure equity in access to vaccination against COVID‑19 for persons with disabilities.
• Joint note on means to protect health care from acts of violence in the COVID-19 vaccination rollout in fragile, conflict-affected and vulnerable settings outlines specific actions for consideration at operational level to ensure the provision of COVID-19 vaccines, unhindered by any acts of violence or obstruction.
• The guidance note and checklist for tackling gender-related barriers to equitable COVID-19 vaccine deployment provides a set of practical actions for countries to implement and ensure gender equality and equity in the deployment of COVID-19 vaccines.